LIX1L and non-small cell lung carcinoma: Limb expression 1‐like protein (LIX1L), as an RNA‐binding protein, is essential for post‐transcriptional regulation and has been identified to significantly influence NSCLC progression, particularly by facilitating epithelial–mesenchymal transition (EMT), a key step in cancer metastasis.